Cargando…
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation
INTRODUCTION: Histologic transformation from non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a well-recognized mechanism of resistance in EGFR-mutant adenocarcinoma upon treatment with TKIs, but rarely reported with programmed death1 (PD-1) inhibitors. We report two cases of p...
Autores principales: | Abdallah, Nadine, Nagasaka, Misako, Abdulfatah, Eman, Shi, Dongping, Wozniak, Antoinette J, Sukari, Ammar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207227/ https://www.ncbi.nlm.nih.gov/pubmed/30498383 http://dx.doi.org/10.2147/LCTT.S173724 |
Ejemplares similares
-
A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors
por: Nagasaka, Misako, et al.
Publicado: (2019) -
Is this really just “fatigue”? A case series of immune‐related central adrenal insufficiency secondary to immune checkpoint inhibitors
por: Nagasaka, Misako, et al.
Publicado: (2018) -
PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report
por: Nagasaka, Misako, et al.
Publicado: (2016) -
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
por: Nagasaka, Misako, et al.
Publicado: (2021) -
Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer
por: Azar, Ibrahim, et al.
Publicado: (2021)